Aragon Pharmaceuticals Inc Garners $8,000,000 Series A Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0e5c8e7c-c266-4e40-89e1-de03041bb307&Preview=1 -
Date
5/21/2009 -
Company Name
Aragon Pharmaceuticals Inc -
Mailing Address
6755 Mira Mesa Blvd San Diego, CA 92121 -
Company Description
Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. -
Website
http://www.aragonpharmaceuticals.com -
Transaction Type
Venture Equity -
Transaction Amount
$8,000,000 -
Transaction Round
Series A -
Proceeds Purposes
The company said the funding will be used to develop new small molecule drugs for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer. -
M&A Terms
-
Venture Investor
The Column Group -
Venture Investor
OrbiMed
